BARKLEY WHNP DIAGNOSTIC READINESS
TEST (DRT) | COMPLETE PRACTICE EXAM
WITH VERIFIED QUESTIONS AND CORRECT
ANSWERS PLUS RATIONALES 2026 Q&A |
INSTANT DOWNLOAD PDF
CORE DOMAINS
• Well-Woman Gynecology & Preventive Care (screening
guidelines, immunizations, health maintenance)
• Reproductive Health & Contraception (family planning,
contraceptive methods, infertility)
• Gynecologic Disorders & Conditions (abnormal uterine bleeding,
endometriosis, PCOS, fibroids, pelvic pain)
• Breast Health & Disorders (screening, benign conditions, breast
cancer risk assessment)
• Obstetric Care (antepartum, intrapartum, postpartum, high-risk
pregnancy)
• Sexually Transmitted Infections (diagnosis, treatment, prevention,
partner management)
• Menopause & Perimenopause (management of vasomotor
symptoms, hormone therapy, genitourinary syndrome)
• Primary Care for Women (cardiovascular health, bone health,
mental health, thyroid disorders)
• Pharmacology & Prescribing (pharmacokinetics,
pharmacodynamics, medication safety in pregnancy/lactation)
, • Ethics, Legal Issues, & Professional Practice (informed consent,
confidentiality, cultural competence, scope of practice)
INTRODUCTION
This comprehensive practice examination is designed to prepare Women's
Health Nurse Practitioner candidates for the Barkley Diagnostic Readiness
Test (DRT) and the NCC WHNP-BC certification examination. The
assessment evaluates critical knowledge areas including well-woman
gynecology, reproductive health, obstetric care, gynecologic disorders,
breast health, menopause management, and primary care for women. All
100 multiple-choice and scenario-based questions mirror the structure,
difficulty, and content distribution of the actual Barkley DRT, emphasizing
applied clinical competence and evidence-based practice. Success
requires mastery of foundational theory, current clinical guidelines
(ASCCP, ACOG, USPSTF), and regulatory standards. Mastery is defined as
achieving ≥80% on both the total test score and within every subject area.
EXAM FORMAT OVERVIEW
Component Details
Number of
100 multiple-choice items
Questions
Time Allowed 100 minutes
Remediation
45-minute review of incorrect answers with detailed rationale
Session
,Component Details
Mastery
≥ 80% total score AND within every subject area
Threshold
Contact Hours 2.5 contact hours available (requires ≥ 70% on second attemp
Each DRT may be taken a maximum of 2 times per purchase
Retake Policy
(First Assessment and Final Assessment)
Access Period 6 months from date of purchase
SECTION ONE: QUESTIONS 1–100
WELL-WOMAN GYNECOLOGY & PREVENTIVE CARE (Questions
1–25)
Question 1
A 22-year-old woman presents for her first Pap test. According to
current ASCCP guidelines, cervical cancer screening with cytology
alone should begin at what age?
A. 18
B. 21
C. 25
D. 30
B
RATIONALE: The American Society for Colposcopy and Cervical
Pathology (ASCCP) and USPSTF recommend initiating cervical cancer
screening at age 21, regardless of sexual history. Screening before age
, 21 is not recommended due to the high likelihood of transient HPV
infections that resolve spontaneously.
Question 2
A 30-year-old woman has a Pap test with HPV co-testing. The result is
negative for intraepithelial lesion or malignancy (NILM) and HPV
negative. What is the recommended follow-up?
A. Repeat co-testing in 1 year
B. Repeat co-testing in 3 years
C. Repeat co-testing in 5 years
D. Colposcopy
C
RATIONALE: For women aged 30–65 with a negative co-test (NILM
and HPV negative), routine screening is recommended no sooner than
every 5 years. This extended interval is safe due to the low risk of
cervical cancer in this population.
Question 3
Which of the following is a known risk factor for cervical cancer?
A. Multiparity
B. Persistent infection with high-risk HPV types 16 and 18
C. Early menopause
D. Endometriosis
B
RATIONALE: Persistent infection with oncogenic (high-risk) HPV
types, especially 16 and 18, is the primary cause of cervical cancer. HPV
is responsible for approximately 99% of cervical cancer cases.
TEST (DRT) | COMPLETE PRACTICE EXAM
WITH VERIFIED QUESTIONS AND CORRECT
ANSWERS PLUS RATIONALES 2026 Q&A |
INSTANT DOWNLOAD PDF
CORE DOMAINS
• Well-Woman Gynecology & Preventive Care (screening
guidelines, immunizations, health maintenance)
• Reproductive Health & Contraception (family planning,
contraceptive methods, infertility)
• Gynecologic Disorders & Conditions (abnormal uterine bleeding,
endometriosis, PCOS, fibroids, pelvic pain)
• Breast Health & Disorders (screening, benign conditions, breast
cancer risk assessment)
• Obstetric Care (antepartum, intrapartum, postpartum, high-risk
pregnancy)
• Sexually Transmitted Infections (diagnosis, treatment, prevention,
partner management)
• Menopause & Perimenopause (management of vasomotor
symptoms, hormone therapy, genitourinary syndrome)
• Primary Care for Women (cardiovascular health, bone health,
mental health, thyroid disorders)
• Pharmacology & Prescribing (pharmacokinetics,
pharmacodynamics, medication safety in pregnancy/lactation)
, • Ethics, Legal Issues, & Professional Practice (informed consent,
confidentiality, cultural competence, scope of practice)
INTRODUCTION
This comprehensive practice examination is designed to prepare Women's
Health Nurse Practitioner candidates for the Barkley Diagnostic Readiness
Test (DRT) and the NCC WHNP-BC certification examination. The
assessment evaluates critical knowledge areas including well-woman
gynecology, reproductive health, obstetric care, gynecologic disorders,
breast health, menopause management, and primary care for women. All
100 multiple-choice and scenario-based questions mirror the structure,
difficulty, and content distribution of the actual Barkley DRT, emphasizing
applied clinical competence and evidence-based practice. Success
requires mastery of foundational theory, current clinical guidelines
(ASCCP, ACOG, USPSTF), and regulatory standards. Mastery is defined as
achieving ≥80% on both the total test score and within every subject area.
EXAM FORMAT OVERVIEW
Component Details
Number of
100 multiple-choice items
Questions
Time Allowed 100 minutes
Remediation
45-minute review of incorrect answers with detailed rationale
Session
,Component Details
Mastery
≥ 80% total score AND within every subject area
Threshold
Contact Hours 2.5 contact hours available (requires ≥ 70% on second attemp
Each DRT may be taken a maximum of 2 times per purchase
Retake Policy
(First Assessment and Final Assessment)
Access Period 6 months from date of purchase
SECTION ONE: QUESTIONS 1–100
WELL-WOMAN GYNECOLOGY & PREVENTIVE CARE (Questions
1–25)
Question 1
A 22-year-old woman presents for her first Pap test. According to
current ASCCP guidelines, cervical cancer screening with cytology
alone should begin at what age?
A. 18
B. 21
C. 25
D. 30
B
RATIONALE: The American Society for Colposcopy and Cervical
Pathology (ASCCP) and USPSTF recommend initiating cervical cancer
screening at age 21, regardless of sexual history. Screening before age
, 21 is not recommended due to the high likelihood of transient HPV
infections that resolve spontaneously.
Question 2
A 30-year-old woman has a Pap test with HPV co-testing. The result is
negative for intraepithelial lesion or malignancy (NILM) and HPV
negative. What is the recommended follow-up?
A. Repeat co-testing in 1 year
B. Repeat co-testing in 3 years
C. Repeat co-testing in 5 years
D. Colposcopy
C
RATIONALE: For women aged 30–65 with a negative co-test (NILM
and HPV negative), routine screening is recommended no sooner than
every 5 years. This extended interval is safe due to the low risk of
cervical cancer in this population.
Question 3
Which of the following is a known risk factor for cervical cancer?
A. Multiparity
B. Persistent infection with high-risk HPV types 16 and 18
C. Early menopause
D. Endometriosis
B
RATIONALE: Persistent infection with oncogenic (high-risk) HPV
types, especially 16 and 18, is the primary cause of cervical cancer. HPV
is responsible for approximately 99% of cervical cancer cases.
